2007
DOI: 10.18553/jmcp.2007.13.9.778
|View full text |Cite
|
Sign up to set email alerts
|

Economic Burden of Atopic Manifestations in Patients With Atopic Dermatitis - Analysis of Administrative Claims

Abstract: BACKGROUND: Atopic dermatitis (AD) has been associated with atopic manifestations (AMs), such as food allergies, asthma, allergic rhinitis, and allergic conjunctivitis.OBJECTIVES: To (1) compare the risk of developing AMs in patients with AD versus those without AD, (2) estimate the incremental costs attributable to AMs in patients with AD, and (3) examine the factors associated with incremental costs.METHODS: In this retrospective cohort study, the authors used MarketScan research databases containing medical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0
1

Year Published

2007
2007
2019
2019

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(29 citation statements)
references
References 33 publications
0
28
0
1
Order By: Relevance
“…[5] Since severe AD in children creates a burden to themselves, to their families and to society, it has become a serious public health issue across the world. [2,6,7] Importantly, AD has been reported to show a high degree of association with other nonallergic disease, including psychiatric and behavior disorders. [2,8,9] …”
Section: Introductionmentioning
confidence: 99%
“…[5] Since severe AD in children creates a burden to themselves, to their families and to society, it has become a serious public health issue across the world. [2,6,7] Importantly, AD has been reported to show a high degree of association with other nonallergic disease, including psychiatric and behavior disorders. [2,8,9] …”
Section: Introductionmentioning
confidence: 99%
“…In the United States, the disease prevalence and annual cost of AD in 2002 were estimated to be 15% to 30% and US$0.9~3.8 billion (1~4.3 trillion KRW)11, respectively. Findings from other countries suggest the global burden of AD will continue to increase steadily.…”
Section: Discussionmentioning
confidence: 99%
“…10 While this research informs us about the subsequent development of AMs in patients newly diagnosed with AD (i.e., that AD preceded AM), research with administrative claims data cannot inform us about causality (i.e., whether AD caused AM). In addition the authors' measurement of direct medical cost in patients with medical claims with diagnosis codes for AMs, including contact dermatitis, eczema, food allergies, allergic rhinitis, allergic conjunctivitis, and asthma, is subject to the limitations of claims databases.…”
Section: ■■ Atopic March To a Dead End Or Does The Theory Really Havementioning
confidence: 95%